Eye Drop Recall: FDA Warns 27 Products May Cause Bacterial Infections

If you have ever tossed a bottle of eye drops into a purse, backpack, or bathroom drawer and assumed it was basically harmless, the FDA’s 2023 eye-drop warning was a sharp reminder that “over the counter” does not mean “risk free.” In fact, when it comes to products that go directly into your eyes, the standard is much higher: they are supposed to be sterile. Not “mostly clean.” Not “probably okay.” Sterile.

That is why the FDA’s warning about 27 eye-drop products landed with such force. These were not obscure products hiding in a mysterious corner of the internet. They were sold under familiar store and distributor labels, including CVS Health, Rite Aid, Target Up & Up, Rugby, Leader, Velocity Pharma, and Walmart’s Equate brand. The concern was not just inconvenience or mild irritation. The agency warned that contaminated eye drops could raise the risk of eye infections that, in serious cases, can lead to partial vision loss or blindness.

And yes, that is the sort of sentence that makes people sprint to the medicine cabinet.

A quick reality check on the headline

Before we go further, here is the important date context: this headline refers to the FDA’s warning and recall activity from late 2023. The agency first warned consumers on October 27, 2023, about 26 over-the-counter eye-drop products. A few days later, the FDA updated the list to add Walmart’s Equate Hydration PF Lubricant Eye Drop, bringing the total to 27. Then, on November 15, 2023, manufacturer Kilitch Healthcare India Limited issued a voluntary nationwide recall covering the affected products.

That timeline matters because people still search for this recall today, either because they want to understand what happened, they are researching product safety, or they have become understandably suspicious of any bottle with the words “lubricating tears” on it. Fair enough.

What exactly was recalled?

The recalled products were a mix of lubricant eye drops, gel drops, and multi-symptom relief drops. They were sold under multiple labels rather than one single household brand, which is one reason the warning felt so wide-reaching. A single manufacturing problem can spread across many retailer-branded products, making the recall look bigger, messier, and more confusing to consumers who think they are buying different items from different sellers.

The affected labels included:

• CVS Health
• Leader (Cardinal Health)
• Rugby (Cardinal Health)
• Rite Aid
• Target Up & Up
• Velocity Pharma
• Walmart Equate

The recall covered all lots within expiry for the listed products, with expiration dates ranging from November 2023 to September 2025. In other words, consumers were not being told to inspect one tiny batch number with a magnifying glass and a prayer. The safer move was simple: if your product matched the affected list, stop using it.

Why the FDA was alarmed

The FDA’s concern centered on sterility risk. Investigators found insanitary conditions at the manufacturing facility and reported positive bacterial test results from environmental sampling in critical drug-production areas. That is bad news in any drug plant, but it is especially serious for ophthalmic products.

Why? Because eye drops bypass some of the body’s normal defenses. Your skin is built to handle a lot of nonsense. Your eyeball is less enthusiastic about that arrangement. A contaminated product applied directly to the eye can introduce microorganisms where they absolutely do not belong.

Later FDA warning letters added more troubling detail to the broader picture. The agency described poor aseptic practices, microbial recoveries in high-grade manufacturing areas, inadequate quality systems, and even problems related to supplier oversight by the U.S. distributor. In plain English: this was not a story about one random bottle going rogue. It was a story about manufacturing controls, sterility assurance, and whether the system meant to protect consumers was working the way it should.

Why eye-drop contamination is such a big deal

There is a reason the FDA and eye specialists did not shrug and say, “Let’s keep an eye on it.” They had already been dealing with a separate but very serious artificial-tears crisis earlier in 2023 involving other products, including EzriCare and Delsam Pharma artificial tears from a different manufacturer. That earlier outbreak was linked to an extensively drug-resistant strain of Pseudomonas aeruginosa, a bacterium that can be extraordinarily difficult to treat.

CDC alerts and later updates showed how severe those consequences could be: dozens of infections, multiple cases of vision loss, and deaths in the broader outbreak investigation. Those earlier events were not the same recall as the 27-product warning, but they created a clear backdrop. By the time the FDA flagged the late-2023 products, regulators and clinicians already knew that contaminated eye drops were not a theoretical problem. They were a real-world, sight-threatening problem.

That history helps explain the strong tone of the FDA warning. When regulators see sterility issues in eye-drop production after a year already marked by serious harm tied to contaminated artificial tears, they do not tend to whisper.

Symptoms to watch for after using recalled eye drops

If someone used one of the recalled products, the first question is obvious: “What would an infection even feel like?” Unfortunately, eye infections do not always make a subtle entrance. They often show up like an uninvited guest kicking down the front door.

Common warning signs

• Eye redness
• Eye pain or worsening discomfort
• Stinging, burning, or irritation
• Watery, yellowish, or greenish discharge
• Blurred vision or decreased vision
• Sensitivity to light
• A gritty or “something is in my eye” feeling
• Crusting on the eyelashes
• Swelling around the eye or eyelid

Some symptoms can sound minor at first. Mild burning. A little redness. A weird sticky feeling in the morning. But when infection is involved, “I’ll just wait it out” is not a great strategy. Eye infections can worsen quickly, and conditions such as keratitis can permanently damage vision if treatment is delayed.

When to seek help fast

If you used a recalled product and then developed pain, discharge, blurred vision, or light sensitivity, contact an eye care professional promptly. If symptoms are severe or rapidly worsening, urgent medical evaluation is the better move. The eye is not the body part to test your optimism on.

What consumers should do if they have one of the recalled products

If you find one of the recalled bottles in your home, the recommended response is not complicated:

1. Stop using it immediately.
2. Discard it properly.
3. Do not donate it, share it, or save it “just in case.”
4. If you have symptoms, call your doctor or seek eye care.
5. If you used the drops but feel fine, stay alert for symptoms and avoid using the product again.

People who wear contact lenses should be especially careful. Contact lenses already increase the risk of certain eye infections when hygiene is poor or lenses are overworn. Adding a questionable eye-drop product to that mix is like inviting a raccoon to manage your pantry. Things can unravel fast.

How to use eye drops more safely going forward

The goal of reading about a recall is not to become terrified of every bottle in the pharmacy aisle. It is to get smarter about what makes an eye-drop product safer and what habits reduce contamination risk.

Smart eye-drop habits

• Wash your hands before using eye drops.
• Do not touch the bottle tip to your eye, fingers, sink, counter, or makeup bag.
• Do not share eye drops with anyone.
• Do not use products with broken seals or damaged packaging.
• Throw away expired products.
• Ask a pharmacist or eye doctor if you are unsure whether a product has been recalled.

Be skeptical of miracle claims

The FDA has also warned consumers about eye products marketed with sketchy promises, such as over-the-counter drops that claim to treat cataracts, glaucoma, macular degeneration, or even change eye color. Those claims should raise eyebrows, and preferably not because something irritating just splashed into them. Consumers should also be cautious with unapproved or improperly marketed eye products, including certain homeopathic or MSM-containing drops flagged by the FDA in separate actions.

Single-use preservative-free vials can make sense for some people

For people with dry eye who use lubricating drops frequently, preservative-free single-use vials may be a good option, especially when used once and discarded right away. They are not magic, but they can reduce some contamination concerns tied to multi-dose containers. As always, the best choice depends on your symptoms, eye history, and guidance from your clinician.

What this recall says about drug safety and oversight

One of the biggest lessons from the eye-drop recalls of 2023 is that product safety does not end when a bottle reaches the shelf. Sterility depends on manufacturing quality, packaging controls, environmental monitoring, supplier oversight, and a regulatory system willing to act quickly when something looks wrong.

The wave of recalls also fueled a broader conversation about whether the FDA needs stronger tools, especially when manufacturers are slow to act. That debate matters because eye drops are common, trusted, and often used without much second thought. Consumers assume a sterile product is actually sterile. That is not a fancy expectation. That is the bare minimum.

It is also worth remembering that prescription eye drops were not the main target of this particular recall. Experts repeatedly emphasized that people should not stop using necessary prescribed eye medications out of generalized fear. The safer takeaway is not “avoid all eye drops forever.” It is “use reputable products, pay attention to recalls, and treat eye symptoms seriously.”

The human side of an eye-drop recall: everyday experiences and lessons

Recalls are usually discussed in regulatory language, but real people experience them in very human ways. A bottle sitting on the bathroom counter is not just a product. It is part of a routine. It belongs to the person who uses artificial tears before work, the parent who keeps drops in a diaper bag, the contact lens wearer who reaches for relief after a long day, or the older adult who has a whole tiny pharmacy lined up beside the sink like an organized row of very judgmental chess pieces.

One common experience is simple disbelief. People see a warning and think, “Wait, these? The same drops I bought at a normal store?” That shock makes sense. Most consumers assume danger comes with dramatic packaging, suspicious online ads, or at least a name like “Doctor Thunder Vision Supreme.” But recalls often involve products that look ordinary and trustworthy. That is what makes them unsettling.

Another common experience is confusion. Many shoppers do not remember the exact brand name, lot number, or where they bought the product. They remember the bottle color. They remember that it was “the dry-eye one.” They remember buying it because it was cheaper than the other brand. Suddenly, a routine errand becomes a scavenger hunt through drawers, glove compartments, travel bags, and coat pockets. Eye drops, it turns out, are excellent at hiding when you most want to throw them away.

Then there is the anxiety of symptoms that may or may not mean something. A person uses a recalled product and later notices redness. Was it the drops? Was it allergies? Lack of sleep? Too much screen time? That uncertainty can be emotionally draining. Even when symptoms turn out to be minor, the waiting period can feel long. Eyes are deeply tied to independence and quality of life, so any threat to vision tends to hit a psychological nerve quickly.

People with chronic dry eye may feel a different frustration: they still need relief. They cannot simply decide to stop blinking dramatically and hope for the best. Dry eye can make reading, driving, computer work, and even being outside uncomfortable. So the recall experience often becomes a balancing act between caution and necessity. The practical answer is not to swear off all treatment, but to switch to safer alternatives and ask an eye-care professional or pharmacist for guidance.

Caregivers face their own version of the problem. They may be managing medications for a parent, spouse, or child and suddenly have one more urgent thing to check. Which bottle is which? Which ones are still safe? Has anyone used the recalled one recently? It is the kind of quiet administrative stress that never makes the headlines but absolutely shapes daily life.

There is also a lesson here about trust. A recall can make people feel betrayed by the system, and honestly, that reaction is not irrational. But the healthier long-term response is not panic. It is vigilance. Check labels. Keep medications organized. Buy eye products from reputable sellers. Toss anything expired, damaged, or suspicious. And if your eye starts sending distress signals, listen. Your body is many things, but subtle about eye pain is usually not one of them.

Final takeaway

The FDA’s warning about 27 eye-drop products was more than a temporary consumer alert. It was a reminder that sterility is not optional when a product goes directly into the eye, and that manufacturing shortcuts can carry very real consequences. The recall also arrived in the shadow of a separate, devastating artificial-tears outbreak earlier in 2023, which gave regulators every reason to take contamination risks seriously.

For consumers, the main lessons are straightforward: know what you are using, stop using recalled products immediately, do not ignore symptoms of infection, and choose eye drops with the same caution you would use for any other product that goes into a sensitive part of your body. Because your eyes, while impressive, are not especially forgiving.